piperacillin and tazobactam
Generic: piperacillin and tazobactam
Labeler: apotex corp.Drug Facts
Product Profile
Brand Name
piperacillin and tazobactam
Generic Name
piperacillin and tazobactam
Labeler
apotex corp.
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
piperacillin sodium 36 g/180mL, tazobactam sodium 4.5 g/180mL
Manufacturer
Identifiers & Regulatory
Product NDC
60505-6262
Product ID
60505-6262_36e76c91-4d5f-402d-addd-eef8d5cef887
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA217243
Listing Expiration
2026-12-31
Marketing Start
2023-09-26
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
605056262
Hyphenated Format
60505-6262
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
piperacillin and tazobactam (source: ndc)
Generic Name
piperacillin and tazobactam (source: ndc)
Application Number
ANDA217243 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 36 g/180mL
- 4.5 g/180mL
Packaging
- 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (60505-6262-0) / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "36e76c91-4d5f-402d-addd-eef8d5cef887", "openfda": {"upc": ["0360505626205"], "unii": ["M98T69Q7HP", "UXA545ABTT"], "rxcui": ["312447"], "spl_set_id": ["c18109cf-d5db-4cc1-83da-537c8ab0e05c"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (60505-6262-0) / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE", "package_ndc": "60505-6262-0", "marketing_start_date": "20230926"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "60505-6262_36e76c91-4d5f-402d-addd-eef8d5cef887", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "60505-6262", "generic_name": "Piperacillin and Tazobactam", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "36 g/180mL"}, {"name": "TAZOBACTAM SODIUM", "strength": "4.5 g/180mL"}], "application_number": "ANDA217243", "marketing_category": "ANDA", "marketing_start_date": "20230926", "listing_expiration_date": "20261231"}